Advertisement
New Zealand markets close in 2 hours 21 minutes
  • NZX 50

    12,112.84
    -10.30 (-0.08%)
     
  • NZD/USD

    0.6055
    -0.0022 (-0.37%)
     
  • NZD/EUR

    0.5558
    -0.0014 (-0.25%)
     
  • ALL ORDS

    8,245.60
    -16.80 (-0.20%)
     
  • ASX 200

    7,998.80
    -18.80 (-0.23%)
     
  • OIL

    81.66
    -0.25 (-0.31%)
     
  • GOLD

    2,433.30
    +4.40 (+0.18%)
     
  • NASDAQ

    20,386.88
    +55.38 (+0.27%)
     
  • FTSE

    8,182.96
    -69.95 (-0.85%)
     
  • Dow Jones

    40,211.72
    +210.82 (+0.53%)
     
  • DAX

    18,590.89
    -157.29 (-0.84%)
     
  • Hang Seng

    17,794.00
    -221.94 (-1.23%)
     
  • NIKKEI 225

    41,362.15
    +171.47 (+0.42%)
     
  • NZD/JPY

    96.0200
    -0.0040 (-0.00%)
     

Why Shares of BioNTech Rose Friday

Why Shares of BioNTech Rose Friday

Shares of BioNTech (NASDAQ: BNTX) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive news regarding a clinical trial for its non-small cell lung cancer therapy candidate. The company focuses on immunotherapies to treat cancer, infectious diseases, and other diseases. BioNTech's shares have been sliding because sales of Comirnaty, the COVID-19 vaccine it developed with Pfizer, are falling.